Publicaciones internacionales
Aquí le ofrecemos una selección de publicaciones científicas relacionadas con la inmunoterapia IOZK.
Puede utilizar los filtros para hacer una selección según tipos de tumores y métodos, o introducir términos de búsqueda.
Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer
Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting
The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy
Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review
The future of cancer vaccines against colorectal cancer
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution
New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy
Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial
Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Oncolytic virus-based combination therapy in breast cancer
Glioblastoma vaccines: past, present, and opportunities
Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development
Decoding immunogenic cell death from a dendritic cell perspective
Targeting immunogenic cell death for glioma immunotherapy
Therapeutic cell-based vaccines for glioblastoma multiforme